As of Jul 01
| 0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 41.00, with a high estimate of 46.00 and a low estimate of 35.00. The median estimate represents a -8.73% decrease from the last price of 44.92.
The current consensus among 6 polled investment analysts is to Buy stock in Enanta Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.